tiprankstipranks
Trending News
More News >
Conduit Pharmaceuticals (CDT)
NASDAQ:CDT
US Market

Conduit Pharmaceuticals (CDT) Income Statement

Compare
408 Followers

Conduit Pharmaceuticals Income Statement

Last quarter (Q3 2025), Conduit Pharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Conduit Pharmaceuticals's net income was $-7.12M. See Conduit Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -457.00K$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 14.96M$ 5.26M$ 3.16M$ 3.17M
Depreciation and Amortization
$ 457.00K$ 0.00$ 0.00$ 0.00
EBITDA
$ -15.84M$ 3.05M$ -4.89M$ -3.17M
Operating Income
$ -15.42M$ -5.26M$ -3.16M$ -3.17M
Other Income/Expenses
$ -2.38M$ 8.10M$ -1.73M$ -484.00K
Pretax Income
$ -17.80M$ 2.84M$ -4.89M$ -3.66M
Net Income
$ -17.80M$ -535.00K$ -4.89M$ -3.66M
Per Share Metrics
Basic EPS
$ -20.53$ -3.60$ -0.07$ -1.01
Diluted EPS
$ -20.53$ -3.60$ -0.07$ -1.01
Weighted Average Shares Outstanding
2.03M 1.67M 3.62M-
Weighted Average Shares Outstanding (Diluted)
2.06M 1.70M 3.62M-
Currency in USD

Conduit Pharmaceuticals Earnings and Revenue History